Guntur, India

Vedantham Ravindra

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Reddy's Laboratories Ltd.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vedantham Ravindra. Retrieved from https://idiyas.com/inventor/vedantham-ravindra

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Vedantham Ravindra

Introduction

Vedantham Ravindra is a notable inventor based in Guntur, India. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on moxifloxacin hydrochloride.

Latest Patents

Ravindra holds a patent for the "Crystalline form III of anhydrous moxifloxacin hydrochloride and a process for preparation thereof." This patent describes a new crystalline form of moxifloxacin monohydrochloride, along with processes for its preparation and various pharmaceutical compositions that utilize this crystalline form.

Career Highlights

Ravindra is associated with Reddy's Laboratories Ltd., a prominent player in the pharmaceutical industry. His work has contributed to advancements in drug formulation and delivery, enhancing the efficacy of treatments.

Collaborations

He has collaborated with notable colleagues such as Manne Satyanarayana Reddy and Sajja Eswaraiah, furthering research and development in their field.

Conclusion

Vedantham Ravindra's innovative contributions to pharmaceutical sciences, particularly through his patent on moxifloxacin hydrochloride, highlight his role as a key inventor in the industry. His work continues to impact the development of effective pharmaceutical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…